1-3 of 3
Maciej Paszkowski-Rogacz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drug

Martin Wermke, Aylin Camgoz, Maciej Paszkowski-Rogacz, Sebastian Thieme, Malte von Bonin, Andreas Dahl, Uwe Platzbecker, Mirko Theis, Gerhard Ehninger, Sebastian Brenner, Martin Bornhäuser, Frank Buchholz
Journal: Blood
Blood (2015) 125 (24): 3760–3768.
https://doi.org/10.1182/blood-2014-07-590646
Published: 2015
Includes: Supplemental data
Journal Articles

A Genome Wide shRNA Screen In Primary Human AML Cells Identifies ROCK1 As a Novel Therapeutic Target

Martin Wermke, MD, Aylin Camgoz, Maciej Paszkowski-Rogacz, PhD, Sebastian Thieme, PhD, Malte von Bonin, MD, Andreas Dahl, PhD, Mirko Theis, PhD, Gerhard Ehninger, MD, Sebastian Brenner, MD, Martin Bornhäuser, MD, Frank Buchholz, PhD
Journal: Blood
Blood (2013) 122 (21): 170.
https://doi.org/10.1182/blood.V122.21.170.170
Published: 2013
Journal Articles

Polycomb group ring finger 1 cooperates with Runx1 in regulating differentiation and self-renewal of hematopoietic cells

Katharina Ross, Anna K. Sedello, Gabriele Putz Todd, Maciej Paszkowski-Rogacz, Alexander W. Bird, Li Ding, Tatyana Grinenko, Kira Behrens, Nina Hubner, Matthias Mann, Claudia Waskow, Carol Stocking, Frank Buchholz
Journal: Blood
Blood (2012) 119 (18): 4152–4161.
https://doi.org/10.1182/blood-2011-09-382390
Published: 2012
Includes: Supplemental data